Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 30
- Page suivante
Title | Authors | Year | Journal | Link to Article | Intended Audience Trier par ordre décroissant | Purpose |
---|---|---|---|---|---|---|
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial | Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke HP, Carroll J, Grewal D, Brar S, Bussieres J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M, Karkouti K, FIBRES Research Group | 2019 | JAMA | View Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial | Health care providers | Clinical research |
Administration de produits sanguins | O'Reilly C | 2021 | Guide de la pratique transfusionnelle | View Administration de produits sanguins | Health care providers | Benchmarking and standard setting |
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies | Warkentin TE | 2020 | Hämostaseologie | View Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies | Health care providers | Clinical research |
Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances | McVey MJ, Cohen R, Arsenault V, Escorcia A, Tasmin F, Pendergrast J, Lieberman L, Lin Y, Callum J, Cserti-Gazdewich C | 2021 | Vox Sang | View Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances | Health care providers | Clinical research |
Vox Sanguinis International forum on the selection and preparation of blood components for intrauterine transfusion | Clarke G, Bodnar M, Lozano M, Nadarajan VS, Lee C, Baud D, Canellini G, Gleich-Nagel T, Torres OW, Rey PL, Bub CB, Kutner JM, Castilho L, Saifee NH, Delaney M, Nester T, Wikman A, Tiblad E, Pierelli L, Matteocci A, Maresca M, Maisonneuve E, Cortey A, Jouannic J-M, Fornells J, Albersen A, de Haas M, Oepkes D, Lieberman L | 2020 | Vox Sang | View Vox Sanguinis International forum on the selection and preparation of blood components for intrauterine transfusion | Health care providers | Benchmarking and standard setting |
Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Health care providers | Benchmarking and standard setting |
Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Liwski R, Clarke G, Cheng C, Abidi SSR, Abidi SR, Quinn JG | 2023 | Vox Sang | View Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Health care providers | New or improved product or process |
A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework | Barty RL, Gagliardi K, Owens W, Lauzon D, Scheuermann S, Liu Y, Wang G, Pai M, Heddle NM | 2015 | Transfusion | View A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework | Health care providers | Benchmarking and standard setting |
Blood donation testing and the safety of the blood supply | Goldman M | 2017 | Practical Transfusion Medicine, 5th Edition | View Blood donation testing and the safety of the blood supply | Health care providers | Benchmarking and standard setting |
Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness | Spradbrow J, Cohen R, Lin Y, Armali C, Collins A, Cserti-Gazdewich C, Lieberman L, Pavenski K, Pendergrast J, Webert K, Callum J | 2016 | Transfusion | View Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness | Health care providers | Benchmarking and standard setting |
Getting the Most Out of the Evidence for Transfusion Medicine | Stanworth SJ, Brunskill SJ, Doree C, Sally Hopewell S, Arnold D | 2013 | Practical Transfusion Medicine, 4th edition | View Getting the Most Out of the Evidence for Transfusion Medicine | Health care providers | Other |
Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review | Hsia C, Liu Y, Eckert K, Monga N, Elia-Pacitti J, Heddle NM | 2015 | Drugs Real World Outcomes | View Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review | Health care providers | Clinical research |
Our older population: donors as well as recipients? | Goldman M, O'Brien S | 2017 | ISBT Sci Ser | View Our older population: donors as well as recipients? | Health care providers | Clinical research |
Point of care ultrasound in haemophilia: Building a strong foundation for clinical implementation | Lawson W, Uy M, Strike K, Iorio A, Stein N, Koziol L, Chan A | 2017 | Haemophilia | View Point of care ultrasound in haemophilia: Building a strong foundation for clinical implementation | Health care providers | Clinical research |
The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia | Arnold DM, Vrbensky JR, Karim N, Smith JW, Liu Y, Ivetic N, Kelton JG, Nazy I | 2017 | Br J Haematol | View The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia | Health care providers | Clinical research |
Two cases of the variant RHD* DAU5 allele associated with maternal alloanti-D | Duncan J, Nahirniak S, Onell R, Clarke G | 2017 | Immunohematology | View Two cases of the variant RHD* DAU5 allele associated with maternal alloanti-D | Health care providers | Clinical research |
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon M-C, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS | 2018 | Lancet Haematol | View Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Health care providers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | McEneny-King A, Chelle P, Iorio A, Edginton AN | 2018 | Thromb Res | View The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | Health care providers | Clinical research |
Anti-Kpa | Peng S, Meunier D | 2019 | Blood.ca website | View Anti-Kpa | Health care providers | Clinical research |
Lewis System: Anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Lewis System: Anti-Lewis | Health care providers | Benchmarking and standard setting |
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 | Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, Cooper J, Thiara S, Foster D, Chen LYC, Lee AYY, Conway EM, Wellington CL, Sekhon MS | 2020 | Blood Adv | View The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 | Health care providers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Bartoszko J | 2021 | Blood.ca website | View Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Health care providers | Clinical research |
An online immunohematology educational resource for post-graduate hematology trainees: LearnSerology.ca | Arsenault V, Yan MTS, Tait G, Lewin A, Pendergrast J | 2023 | Transfus Apher Sci | View An online immunohematology educational resource for post-graduate hematology trainees: LearnSerology.ca | Health care providers | Education research |
Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Chi SI, Kumaran D, Zeller MP, Ramirez-Arcos S | 2022 | Annals of Blood | View Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Health care providers | Clinical research |
Emicizumab state-of-the-art update | Mahlangu J, Iorio A, Kenet G | 2022 | Haemophilia | View Emicizumab state-of-the-art update | Health care providers | Clinical research |
How do I/we forecast tomorrows’ transfusion: Blood components | Pereyra N, Devine DV | 2023 | Transfus Clin Biol | View How do I/we forecast tomorrows’ transfusion: Blood components | Health care providers | New or improved product or process |
A Guide to Reporting Adverse Transfusion Events | Canadian Blood Services | 2014 | Blood.ca website | View A Guide to Reporting Adverse Transfusion Events | Health care providers | Other |
ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis | Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J | 2018 | Blood | View ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis | Health care providers | Clinical research |
Circular of Information for the use of human blood components: Platelets | Jenkins C | 2017 | Blood.ca website | View Circular of Information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Donner au suivant : pourquoi nous avons besoin que VOUS donniez du sang | Callum J | 2017 | Blood.ca website | View Donner au suivant : pourquoi nous avons besoin que VOUS donniez du sang | Health care providers | Other |
Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study | Shih AW, Kolesar E, Ning S, Manning N, Arnold DM, Crowther MA | 2015 | Vox Sang | View Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study | Health care providers | New or improved product or process |
Hemoglobin C in a patient with sickle cell anemia: Transfusion-acquired SC disease | Estey MP, Capote KR, Barakauskas VE, Clarke G, Higgins T | 2015 | Clin Biochem | View Hemoglobin C in a patient with sickle cell anemia: Transfusion-acquired SC disease | Health care providers | Clinical research |
Management of immune-mediated thrombocytopenia | Arnold DM, Nazi I, Smith JW, Warkentin TE | 2016 | Rossi's Principles of Transfusion Medicine | View Management of immune-mediated thrombocytopenia | Health care providers | Clinical research |
Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | van Schalkwyk J, Nourmoussavi M, Massey A, Gustafson R, Brodkin E, Petric M, Krajden M, Dobson S, Buxton J, Bigham M, Pick N, Schreiber R, Sherlock CH, Money D, Yoshida EM | 2014 | Can J Gastroenterol Hepatol | View Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | Health care providers | Clinical research |
New cancers after autotransplantations for multiple myeloma | Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN | 2015 | Biol Blood Marrow Transplant | View New cancers after autotransplantations for multiple myeloma | Health care providers | Clinical research |
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Zeller M, Arnold DM | 2015 | Am J Hematol | View Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Health care providers | Clinical research |
Using pharmacokinetics to individualize hemophilia therapy | Iorio A | 2017 | Hematology Am Soc Hematol Educ Program | View Using pharmacokinetics to individualize hemophilia therapy | Health care providers | Clinical research |
Within-individual mean corpuscular volume variation | Cembrowski G, Topping K, Clarke G | 2014 | Arch Pathol Lab Med | View Within-individual mean corpuscular volume variation | Health care providers | Other |
Signalement des réactions transfusionnelles indésirables | Chargé S, Young D | 2018 | Blood.ca website | View Signalement des réactions transfusionnelles indésirables | Health care providers | Other |
Concentrates for Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Concentrates for Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Rh System: Anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Rh System: Anti-V | Health care providers | Benchmarking and standard setting |
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima KM, Speedy J, Bruun MT, Dunbar NM | 2021 | Vox Sang | View International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Health care providers | Benchmarking and standard setting |
Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice | Morin P-A, Skeate R, Clarke G | 2020 | Blood.ca website | View Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice | Health care providers | Benchmarking and standard setting |
The unique characteristics of COVID-19 coagulopathy | Iba T, Levy J, Conors J, Warkentin T, Tachil J, Levi M | 2020 | Crit Care | View The unique characteristics of COVID-19 coagulopathy | Health care providers | Clinical research |
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Sirotich E, Guyatt G, Gabe C, Ye Z, Beck CE, Breakey V, Cooper N, Cuker A, Charness J, de Wit K, DiRaimo J, Fein SG, Grace RF, Hassan Z, Jamula E, Kang M, Manski CF, O'Connor C, Pai M, Paynter D, Porter SC, Pruitt B, Strachan G, Webert KE, Yan JW, Kelton JG, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Réactions transfusionnelles anaphylactiques et déficit en IgA | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Réactions transfusionnelles anaphylactiques et déficit en IgA | Health care providers | Benchmarking and standard setting |
Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Dunbar NM, Kaufman RM | 2021 | Transfusion | View Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Health care providers | Benchmarking and standard setting |
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Al-Riyami AZ, Burnouf T, Wood EM, Devine DV, Oreh A, Apelseth TO, Goel R, Bloch EM, van Den Berg K, Getshen M, Louw V, Ang AL, Lee CK, Rahimi-Levene N, Stramer SL, Vassallo R, Schulze TJ, Patidar GK, Pandey HC, Dubey R, Badawi M, Hindawi S, Meshi A, Matsushita T, Sorrentino E, Grubovic Rastvorceva RM, Bazin R, Vermeulen M, Nahirniak S, Tsang HC, Vrielink H, Triyono T, Addas-Carvalho M, He?imovi? A, Torres OW, Mutindu SM, Bengtsson J, Dominguez D, Sayedahmed A, Hanisa Musa R, Gautam B, Herczenik E, So-Osman C, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Health care providers | Benchmarking and standard setting |